NanoViricides
NNVC
#10078
Rank
HK$0.16 B
Marketcap
HK$7.66
Share price
2.12%
Change (1 day)
-15.01%
Change (1 year)

Market capitalization of NanoViricides (NNVC)

Market cap: HK$0.16 Billion

As of March 2026 NanoViricides has a market cap of HK$0.16 Billion. This makes NanoViricides the world's 10078th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of NanoViricides from 2007 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$0.16 B-17.15%
2025HK$0.19 B19.53%
2024HK$0.16 B78.55%
2023HK$93.57 M-7.07%
2022HK$0.10 B-69.88%
2021HK$0.33 B40.89%
2020HK$0.23 B213.61%
2019HK$75.66 M-30.49%
2018HK$0.10 B-75.01%
2017HK$0.43 B-9.82%
2016HK$0.48 B-8.68%
2015HK$0.52 B-55.69%
2014HK$1.19 B-35.93%
2013HK$1.86 B221.15%
2012HK$0.57 B-18.03%
2011HK$0.70 B-55.44%
2010HK$1.58 B82.63%
2009HK$0.86 B13.19%
2008HK$0.76 B111.98%
2007HK$0.36 B

End of Day market cap according to different sources

On Mar 8th, 2026 the market cap of NanoViricides was reported to be:

HK$0.16 Billion
by Nasdaq info icon info icon
HK$0.16 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Gilead Sciences
GILD
HK$1.423 T 860,026.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$2.263 T 1,368,044.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$965.28 B 583,327.78%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$869.59 B 525,486.45%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
HK$13.43 B 8,022.51%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
HK$16.90 B 10,115.43%๐Ÿ‡บ๐Ÿ‡ธ USA